Graf Akcie ICUI (ICU Medical, Inc.). Diskuze k akciím ICUI. Aktuální informace ICUI.

Základní informace o společnosti ICU Medical, Inc. (Akcie ICUI)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 4.77B
Hodnota podniku (EV) 4.61B
Tržby 1.279B
EBITDA 232.116M
Zisk 103.257M
Růst v tržbách Q/Q 6.03 %
Růst v tržbách Y/Y 1.89 %
P/E (Cena vůči ziskům) 47.11
Forward P/E 5.37
EV/Sales 3.60
EV/EBITDA 19.84
EV/EBIT 38.60
PEG 5.01
Price/Sales 3.73
P/FCF 27.30
Price/Book 3.18
Účetní hodnota na akcii 72.69
Hotovost na akcii 19.88
FCF vůči ceně 3.66 %
Počet zaměstnanců 7,900
Tržba na zaměstnance 161.866k
Profit margin 6.83 %
Operating margin 9.38 %
Gross margin 36.31 %
EBIT margin 9.33 %
EBITDA margin 18.15 %
EPS - Zisk na akcii 4.90
EPS - Kvartální růst 13.94 %
EPS - Očekávaný růst příští rok -5.26 %
Return on assets 5.85 %
Return on equity 6.85 %
ROIC 5.74 %
ROCE 7.37 %
Dluhy/Equity 0.17
Čistý dluh/EBITDA -7.27
Current ratio 5.30
Quick Ratio 3.67
Volatilita 2.98
Beta 0.61
RSI 50.62
Cílová cena analytiků 224
Známka akcie (dle analytiků) N/A
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 21.208M
Procento shortovaných akcií 2.84 %
Short ratio 3.89 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1992
Země United States

Finanční výsledky akcie ICUI

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$1,266.208$1,400.04$1,292.613$379.372$341.668$309.26
Cost Of Goods Sold$794.344$830.012$866.518$177.974$160.871$157.859
Gross Profit$471.864$570.028$426.095$201.398$180.797$151.401
Research And Development Expenses$48.611$52.867$51.253$12.955$15.714$18.332
SG&A Expenses$276.982$320.002$302.169$89.426$83.216$88.939
Other Operating Income Or Expenses$41.663$-62.013$-8$-0.728$-4.851-
Operating Expenses$1,158.848$1,370.284$1,305.907$296.431$273.103$270.223
Operating Income$107.36$29.756$-13.294$82.941$68.565$39.037
Total Non-Operating Income/Expense$7.347$-7.382$64.577$2.223$1.134$0.755
Pre-Tax Income$114.707$22.374$51.283$85.164$69.699$39.792
Income Taxes$13.672$-6.419$-17.361$22.08$24.714$13.457
Income After Taxes$101.035$28.793$68.644$63.084$44.985$26.335
Other Income------
Income From Continuous Operations$101.035$28.793$68.644$63.084$44.985$26.335
Income From Discontinued Operations------
Net Income$101.035$28.793$68.644$63.084$44.985$26.335
EBITDA$192.993$105.121$53.426$103.346$88.308$60.672
EBIT$107.36$29.756$-13.294$82.941$68.565$39.037
Basic Shares Outstanding212020161615
Shares Outstanding222221171616
Basic EPS$4.90$1.41$3.50$3.90$2.84$1.72
EPS - Earnings Per Share$4.69$1.33$3.29$3.66$2.73$1.68
# 2020 2019 2018 2017 2016 2015
Current Ratio3.55053.71874.111714.03911.849615.056
Long-term Debt / Capital------
Debt/Equity Ratio------
Gross Margin37.265940.715132.963953.087252.91648.9559
Operating Margin8.47892.1254-1.028521.862720.067712.6227
EBIT Margin8.47892.1254-1.028521.862720.067712.6227
EBITDA Margin15.24187.50844.133227.241325.846119.6185
Pre-Tax Profit Margin9.05911.59813.967422.448720.399612.8668
Net Profit Margin7.97932.05665.310516.628513.16638.5155
Asset Turnover0.74820.88310.86350.53840.54510.5715
Inventory Turnover Ratio2.35262.66753.00193.61273.6874.2742
Receiveable Turnover6.26167.94136.11166.75515.90647.9194
Days Sales In Receivables58.292145.962159.722954.033461.797346.0894
ROE - Return On Equity7.3362.27855.72879.55597.75785.1815
Return On Tangible Equity8.9052.5736.58689.97868.18695.27
ROA - Return On Assets5.971.81614.58568.9527.17664.8669
ROI - Return On Investment7.3362.27855.72879.55597.75785.1815
Book Value Per Share66.398861.668859.290240.406136.048232.5907
Operating Cash Flow Per Share-2.68650.01352.19071.3213-0.3483-0.0633
Free Cash Flow Per Share-3.5466-0.071-0.21530.7260.14330.0782